Andrew White's questions to 22nd Century Group Inc (XXII) leadership • Q2 2025
Question
The analyst inquired about the updated timeline for achieving EBITDA breakeven, the sufficiency of current cash reserves to reach that point, plans for handling debt maturing in 2026, and the likelihood of the VLN MRTP authorization being renewed by the FDA.
Answer
Management now expects to reach EBITDA breakeven in the first half of 2026, likely Q2. They acknowledged that a near-term capital raise might be necessary, though smaller than past raises. The company is in discussions to pay off its debt and is highly confident that the VLN MRTP will be renewed, given its alignment with the FDA's proposed mandate.